Voyager Acquisition Corp. VACH
1.85 USD 0.00 (+0.00%)
Aug 4, 2026, 9:30 AM EDT
1.84 Day range 1.85
52-week range unavailable
- YTD
- -82.66%
- 1 year
- -82.16%
News
benzinga.com VERAXA Biotech And Voyager Acquisition Complete Business Combination; On June 11, 2026, VERAXA Will Commence Trading Its Shares Under The Symbol "VRXA" Business combination transaction with Voyager Acquisition Corp. complete, creating a Nasdaq-listed, innovative biopharmaceutical company focused on next-generation cancer therapies of novel…
globenewswire.com VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026 The business combination of VERAXA Biotech and Voyager Acquisition Corp. was closed successfully and NASDAQ trading of $VRXA commences on June 11, 2026.
benzinga.com Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering to fund AI orders. Other stocks also down in pre-market trading.
globenewswire.com VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement Transactions Provide Financial Flexibility to Advance Pipeline of Next Generation Cancer Therapies Comprised of Novel Bispecific T-cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs) Support…
benzinga.com GE Vernova, Boston Scientific, Intuitive Surgical And Other Big Stocks Moving Higher On Wednesday U.S. stocks were higher, with the Dow Jones gaining over 350 points on Wednesday. GE Vernova shares rose 14.1% after beating estimates and raising sales guidance.
benzinga.com Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TVTX, BE, IONQ, SANA, RGTI, VACH, AOSL.
benzinga.com Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainers include Kodiak Sciences Inc and Precigen Inc.
benzinga.com Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4 results and issuing strong FY26 EPS guidance. Other gainers include LBGJ, ASNS, SVRN, SUNE, MDAI,…
globenewswire.com Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and…
globenewswire.com Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) today announced that holders of 25,217,315 of the…
defenseworld.net Crossingbridge Advisors LLC Acquires Shares of 46,779 Voyager Acquisition Corp. $VACH Crossingbridge Advisors LLC acquired a new position in shares of Voyager Acquisition Corp. (NASDAQ: VACH) during the third quarter, according to the company in its most recent 13F filing with the…
globenewswire.com VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp. VERAXA shareholders approve merger & issuance of new shares to Voyager. Both resolutions are prerequisites for the closing of the business combination.
defenseworld.net Contrasting Blaize (NASDAQ:BZAI) & Voyager Acquisition (NASDAQ:VACH) Blaize (NASDAQ: BZAI - Get Free Report) and Voyager Acquisition (NASDAQ: VACH - Get Free Report) are both small-cap financial services companies, but which is the better business? We will contrast…
prnewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRTAF, LCTC, VACH, and EFIN NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
globenewswire.com VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology Partnership combines Secarna's OligoCreator® platform with VERAXA's technology suite to create next-generation targeted therapies for autoimmune and inflammatory diseases Partnership combines…
globenewswire.com VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands…
globenewswire.com VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted…
globenewswire.com VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO…
globenewswire.com VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO…
globenewswire.com VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies Industry Veteran to Support Acceleration of Key Pipeline Projects and…
benzinga.com VERAXA Biotech Joins Forces with OmniAb to Develop Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors Under the terms of the agreement, VERAXA will initiate a novel bispecific antibody drug conjugate program addressing two attractive target molecules in cancer medicine. The Company will utilize…